Listed Companies > Listed Companies Info. > Emerging Stock Board Companies > Listed Company Profile
ESM Companies
For foreign Emerging Stock Board enterprises, ”*- country of incorporation” indicates stocks without par value or with par value other than NT$10, and ”- country of incorporation” indicates stocks with par value of NT$10 per share.
Code:
Industry:
Please select domestic/foreign stock:
6677 Anxo
中文
Basic information
Chairman President Spokesperson Telephone Address ESM Registration Date
Wang Chien-Chih Wang Chien-Chih Hank Chen 02-25042121 8F-3, No.206, Sec. 2, Nanking E. Rd.,Taipei City 104, Taiwan (R.O.C.) 2018/06/27
Industry
category
Key businesses
Biotechnology and Medical Care Anxo pharmaceutical, founded in 2003, is a technology based specialty pharmaceutical company aimed on the development and commercialization of all kinds of potential pharmaceutical generic products. Based on experienced expertise and creativity, Anxo pharmaceutical has successfully developed a serial products spanning fields of DM, CV, CNS, infection, respiratory, GI, ophthalmic, otic and dermatological. Thus far, Anxo has granted 41 ANDAs approval of which includes 13 bioequivants. Anxo’s goal is to become an all-oriented drug developing company in providing more affordable products to consumers as well as expertise service to industry.
 
Market info
Latest trading info Historic trading info
 
Financial data
Cash flows statement Item
Amount(NTD, in thousands)
Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Consolidated/Individual
balance sheet
Current assets
Non-current assets
Total assets
Current liabilities
Non-current liabilities
Total liabilities
Share capital
Capital surplus
Retained earnings
Other equity interest
Treasury shares
Total equity attributable to owners of parent
Non-controlling interests
Total equity
Book Value per share(NT$)
Consolidated/Individual
profit and loss
statement
Operating revenue
Operating costs
Gross profit from operations
Operating expenses
Net other income (expenses)
Net operating income
Non-operating income and expenses
Profit before tax
Tax expense
Profit from continuing operations
Profit from discontinued operations
Profit
Other comprehensive income
Comprehensive income
Basic earnings per share
* Auditor's report on latest financial statements: auditor's report:
* Investors may find more detailed information on the company by visiting the Market Observation Post System.。
* The information disclosed here concerning foreign enterprises consists of amounts provided in consolidated financial statements.